Australians living with generalised myasthenia gravis now have access to a new treatment option under the Pharmaceutical Benefits Scheme, marking a significant milestone for the rare disease community.
Funded therapy gives hope for people living with rare autoimmune disease
March 1, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 1 May
May 1, 2026 - - Podcast -
UCB marks 25 years in Australia and advances national life science strategy
May 1, 2026 - - Latest News -
Stability now, change later? Fees unchanged while department undertakes charging model review
May 1, 2026 - - Latest News -
Bridge Program celebrates ten years of translating research into patient outcomes
May 1, 2026 - - Latest News -
New oral treatment offers more options for Australians with metastatic colorectal cancer
April 30, 2026 - - Latest News -
Moderna taps Salesforce to unify global commercial operations
April 30, 2026 - - Latest News -
How do we know the HTA institution loves patients? Because they use a love heart emoji
April 30, 2026 - - Latest News
